Harlow, B L, Signorello, L B, Hall, J E et al. · The American journal of medicine · 1998 · DOI
This study compared reproductive and menstrual histories in women with ME/CFS to healthy women without the condition. Women with ME/CFS reported more gynecologic problems and irregular menstrual cycles, and researchers found signs suggesting ovarian dysfunction—such as polycystic ovary syndrome (PCOS)—occurred more often in the ME/CFS group. The authors propose that hormonal imbalances affecting egg release may contribute to ME/CFS by reducing protective immune effects from certain hormones.
This study highlights a potential sex-specific biological pathway in ME/CFS etiology involving hormonal dysregulation and immune modulation. Understanding whether reproductive hormonal dysfunction contributes to ME/CFS pathophysiology could inform sex-stratified treatment approaches and help explain why the disease disproportionately affects women.
This study does not establish causation—gynecologic abnormalities may result from CFS rather than precede it, since data were collected after CFS onset. It does not prove that PCOS or ovarian dysfunction causes ME/CFS, only that these conditions are reported more frequently in women with ME/CFS. The mechanism proposed (progesterone immunomodulation) remains theoretical and was not directly tested.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.